<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        24-171-97
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1997
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RANIDINE 150MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        RANITIDINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        150
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        18.15
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1055]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Dallah Health Care Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>RANIDINE contains a medicine called Ranitidine. This belongs to a group of medicines called H2-receptor<br />antagonists. It lowers the amount of acid in your stomach.<br />For adults (including the elderly) RANIDINE is used to:<br />□ Heal and stop ulcers in the stomach or the part of the gut it empties into (the duodenum)<br />□ Help clear up infection in your stomach, when taken with antibiotic medicines (medicines taken to treat germs)<br />□ Stop stomach ulcers when they are a side effect of some medicines<br />□ Stop ulcers from bleeding<br />□ Improve problems caused by acid in the food pipe (oesophagus) or too much acid in the stomach. Both of these<br />can cause pain or discomfort sometimes known as &#39;indigestion&#39;, &#39;dyspepsia&#39; or &#39;heartburn&#39;<br />□ Stop acid coming up from the stomach while under anaesthetic during an operation.<br />For children (3 to 18 years) RANIDINE is used to:<br />□ Heal ulcers in the stomach, of the part of the gut it empties into (the duodenum)<br />□ Heal and stop problems caused by acid in the food pipe (oesophagus) or too much acid in the stomach. Both of<br />these can cause pain or discomfort sometimes known as indigestion, dyspepsia or heartburn</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>□ If you are allergic (hypersensitive) to Ranitidine or any of the other ingredients of RANIDINE (listed in Section 6).<br />If you are not sure, talk to your doctor or pharmacist before taking RANIDINE.<br />Take special care with RANIDINE:<br />Check with your doctor or pharmacist before taking your medicine if:<br />□ You have stomach cancer<br />□ You have kidney problems. You will need to take a different amount of RANIDINE<br />□ You have had stomach ulcers before and you are taking Non-Steroidal Anti Inflammatory (NSAID) medicines<br />□ You have a rare condition called acute porphyria<br />□ You are over 65 years old<br />□ You have lung disease<br />□ You are diabetic<br />□ You have any problems with your immune system.<br />If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before using this medicine.<br />Taking other medicines:<br />Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This includes<br />medicines that you buy without a prescription and herbal medicines. This is because RANIDINE can affect the way<br />some other medicines work. Also some other medicines can affect the way RANIDINE works. In particular tell your<br />doctor or pharmacist if you are taking any of the following medicines:<br />□ Non-Steroidal Anti-Inflammatory (NSAID) medicines, for pain and inflammation<br />□ Lidocaine, a local anaesthetic<br />□ Propranolol, procainamide or n-acetylprocainamide, for heart problems<br />□ Diazepam, for worry or anxiety problems<br />□ Phenytoin, for epilepsy<br />□ Theophylline, for breathing problems (asthma)<br />□ Warfarin, for thinning your blood<br />□ Glipizide, for lowering blood glucose<br />□ Atazanavir or delaviridine, for treating HIV infection<br />□ Triazolam, for insomnia<br />□ Gefitnib, for lung cancerKetoconazole, an anti fungal medicine, sometimes used for treating thrush.<br />Midazolam is a medicine that may be given to you just before you have an operation. Tell the doctor you are taking<br />RANIDINE before your operation in case he or she wants to give you midazolam.<br />If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking RANIDINE.<br />Pregnancy and breast feeding:<br />Pregnancy<br />If you are pregnant, might become pregnant, you should not take RANIDINE unless your doctor advises it is<br />essential. Ask your doctor or pharmacist for advice before taking any medicine, if you are pregnant.<br />Breast-feeding<br />If you are breast-feeding, you should not take RANIDINE unless your doctor advises it is essential. Ask your doctor<br />or pharmacist for advice before taking any medicine, if you are breast-feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take RANIDINE exactly as your doctor has told you. You should check with your doctor or pharmacist if you<br />are not sure.<br />□ Take this medicine by mouth.<br />□ Swallow each tablet whole with a glass of water.<br />The usual dose for an adult (including the elderly) and adolescents (12 years and over) is either:<br />150 mg in the morning and 150 mg in the evening, or 300 mg at bedtime.<br />Your exact dose will depend on your particular stomach condition, your doctor will tell you the dose you should<br />take.<br />Children over 30 kg of weight and from 3 to 11 years:<br />Your doctor will work out the right dose for you based on your child&#39;s weight.<br />□ Treatment of stomach or duodenal (small intestine) ulcers:<br />The usual dose is 2 mg for each kg of body weight, twice a day for four weeks. This dose may be increased to 4mg<br />for each kg, twice a day. Take each dose about 12 hours apart. The duration of treatment may be increased to 8<br />weeks.<br />□ Treatment of heartburn due to too much acid:<br />The usual dose is 2.5 mg for each kg of body weight, twice a day for two weeks. This dose may be increased to 5<br />mg for each kg, twice a day. Take each dose about 12 hours apart.<br />If you take more RANIDINE than you should:<br />RANIDINE is not normally harmful if you take more than you should, unless you take many tablets at once. If this<br />applies to you (or someone else taking this medicine), you should go to your nearest hospital casualty department<br />straight away. Take the medicine pack or any remaining medicine with you so that the doctor knows what you have<br />taken.<br />If you forget to take RANIDINE:<br />If you forget a dose, take it as soon as you remember it, unless it is nearly time for your next dose. Do not take a<br />double dose to make up for a forgotten dose.<br />If you stop taking RANIDINE:<br />After a few days of taking the tablets you should start to feel much better. Do not stop taking the tablets without<br />talking to your doctor or pharmacist first, otherwise the original pain and discomfort may come back. If you have<br />any further questions on the use of this product, ask your doctor or pharmacist</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, RANIDINE can cause side effects, although not everybody gets them.<br />The following side effects may happen with this medicine.<br />Stop taking RANIDINE and see a doctor straight away, if you notice any of the following serious side<br />effects, you may need urgent medical treatment:<br />□ Allergic reactions, the signs may include:<br />- Rash, itching or hives on the skin<br />- Swelling of your face, lips, tongue or other parts of the body<br />- Chest pain, shortness of breath, wheezing or having trouble breathing<br />- Unexplained fever and feeling faint, especially when standing up<br />□ Kidney problems, which can lead to back pain, fever, pain when passing urine, blood in the urine and changes in<br />blood tests<br />□ Severe stomach pain, this may be a sign of something called &#39;pancreatitis&#39;<br />□ A slow or irregular heartbeat<br />Check with your doctor at your next visit if you notice any of the following:<br />Uncommon (affects less than 1 in 100 people):<br />□ Stomach pain<br />□ Constipation<br />□ Feeling sick (nausea)<br />Rare (affects up to 1 in 1,000 people)<br />□ Skin rashRare side effects that may show up in blood tests:<br />□ Increase of serum creatinine in the blood (kidney function test)<br />□ Changes to liver function<br />Check with your doctor as soon as possible if you notice any of the following:<br />Very rare (affect less than 1 in 10,000 people):<br />□ There can be changes in the level of certain substances in your blood. This can lead to you feeling unusually<br />tired or short of breath and being more likely to bruise or get an infection<br />□ Feeling depressed, confused, seeing or hearing unexplained things (hallucinations)<br />□ Headache (sometimes severe)<br />□ Feeling dizzy or having blurred vision<br />□ Your joints or muscles are painful or swollen or you cannot control their movement<br />□ Your small blood vessels can become swollen (known as &#39;vasculitis&#39;). Signs of this can include: a rash, swollen<br />joints or kidney problems<br />□ Your liver can become swollen. This can lead to: nausea (feeling sick) or vomiting (being sick), loss of appetite or<br />generally feeling unwell, itching, fever, yellowing of the skin and eyes or dark coloured urine<br />□ Flushing or marks on your skin that look like targets<br />□ Unexplained hair loss<br />□ Diarrhoea<br />□ Impotence<br />□ Breast tenderness and/or breast enlargement<br />□ Breast discharge.<br />If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor<br />or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>□ Keep out of the reach and sight of children.<br />□ Do not store above 30 &deg;C.<br />□ Do not use RANIDINE after the expiry date which is stated on the carton and on the blister, after (EXP).Date<br />Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of<br />medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What RANIDINE contains:<br />□ The active substance is Ranitidine. Each Tablet contains 150 and 300 mg Ranitidine, respectively, as Ranitidine<br />Hydrochloride.<br />□ The other ingredients are: hydroxypropyl cellulose, colloidal anhydrous silica, magnesium stearate, butylated<br />hydroxyl toluene, titanium dioxide, triacetin</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                RANIDINE Tablets 150 and 300 mg are white to off-white, circular shallow bioconvex film coated tablets with plain
on both sides.
□ Boxes of 20 blistered tablets of RANIDINE 150 Tablets.
□ Boxes of 10 blistered tablets of RANIDINE 300 Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Jordanian pharmaceutical manufacturing co.(P.L.C.|)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                December 2012
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي رانيدين على دواء يدعى رانيتيدين. وهو ينتمي إلى مجموعة من الأدوية تدعى مضادات مستقبل ه ۲. يعمل على تقليل كمية الحمض في<br />معدتك.<br />يستخدم رانيدين لدى البالغين (بما في ذلك كبار السن):<br />لمعالجة وإيقاف قرحة المعدة أو جزء الأمعاء الذي يصب في الاثني عشر □<br />للمساعدة في إزالة العدوى من المعدة، عندما تؤخذ مع أدوية المضادات الحيوية (الأدوية تؤخذ لعلاج الجراثيم) □<br />لإيقاف قرحة المعدة عندما تكون أثر جانبي لبعض الأدوية □<br />لإيقاف النزيف الناتج عن القرحة □<br />لتحسين المشاكل التي يسببها الحمض الموجود في الأنبوب الغذائي (المريء) أو الحمض الكثير الموجود في المعدة والذي يتسبب في الألم □<br />والانزعاج الذي يعرف أحياناً بعسر الهضم أو حرقة المعدة<br />لإيقاف خروج الحمض من المعدة عندما تكون تحت تأثير التخدير أثناء العملية. □<br />يستخدم رانيدين للأطفال (الذين تتراوح أعمارهم من ۳ إلى ۱۸ سنة):<br />لمعالجة قرحة المعدة وجزء الأمعاء الذي يصب في الاثني عشر □<br />لمعالجة و إيقاف المشاكل التي يسببها الحمض الموجود في الأنبوب الغذائي (المريء) أو الحمض الكثير الموجود في المعدة والذي يتسبب في الألم □<br />والانزعاج الذي يعرف أحياناً بعسر الهضم أو حرقة المعدة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>( إذا كنت تعاني من حساسية لرانيتيدين أو أي من مكونات رانيدين الأخرى (المذكورة في القسم ٦ □<br />إذا لم تكن متأكداً، فإن عليك استشارة الطبيب أو الصيدلاني قبل تناول رانيدين.<br />الاحتياطات عند استعمال رانيدين:<br />عليك مراجعة طبيبك أو الصيدلاني قبل تناول رانيدين:<br />إذا كنت تعاني من سرطان في المعدة □<br />إذاكنت تعاني من مشاكل في الكلى، فإنك ستحتاج إلى تناول كميات مختلفة من رانيدين □<br />إذا كنت تعاني مسبقاً من قرحة في المعدة وكنت تتناول الأدوية المضادة للالتهاب غير الستيرويدية □<br />إذا كنت تعاني من حالة نادرة تدعى البرفيرية الحادة □<br />إذا كنت أكبر من ٦٥ سنة □<br />إذا كنت تعاني من مرض رئوي □<br />إذا كنت مصاباً بمرض السكري □<br />إذا كنت تعاني من أي مشاكل في الجهاز المناعي □<br />إذا لم تكن متأكداً مما إذا كان أي من أعلاه ينطبق عليك، فإن عليك التحدث مع طبيبك أو الصيدلاني قبل تناول رانيدين.<br />تناول أدوية أخرى:<br />أخبر طبيبك أو الصيدلاني إذا كنت تستخدم أواستخدمت موخراً أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية<br />والأدوية العشبية. وذلك لأن رانيدين قد يؤثر على آلية العمل لبعض الأدوية، وكذلك بعض الأدوية الأخرى تؤثرعلى آلية عمل رانيدين.<br />عليك إخبار طبيبك أو الصيدلاني إذا كنت تتناول أي من الأدوية التالية على وجه الخصوص:<br />أدوية مضادات الالتهاب غير الستيرويدية، التي تستخدم لعلاج الألم والالتهاب □<br />ليدوكايين، وهو مخدر موضعي □<br />بروبرانولول أو بروكاييناميد أو ن- أسيتيل بروكايينامايد، التي تستخدم لعلاج مشاكل القلب □<br />ديازيبام، لعلاج مشاكل القلق □<br />فينيتوين، لعلاج الصرع □<br />الثيوفيلين، لعلاج مشاكل في التنفس (الربو) □<br />الوارفارين، لمنع تجلط الدمجليبيزايد، لتخفيض مستوى السكر في الدم □<br />أتازانافير أو ديلافيريدين التي تستخدم لعلاج عدوى فيروس نقص المناعة البشرية □<br />تريازولام، لعلاج الأرق □<br />جيفتينب، لعلاج سرطان الرئة □<br />الكيتوكونازول، وهو دواء مضاد للفطريات، ويستخدم أحيانا لعلاج مرض السلاق. □<br />الميدازولام هو دواء يمكن أن يعطى لك فقط قبل العملية الجراحية. عليك أن تخبر الطبيب بأنك تأخذ رانيدين قبل إجراء العملية الخاصة بك في حالة<br />إعطائك الميدازولام.<br />إذا لم تكن متأكداً مما إذا كان أي من أعلاه ينطبق عليك، فإن عليك التحدث مع طبيبك أو الصيدلاني قبل تناول رانيدين.<br />الحمل والإرضاع:<br />الحمل<br />يجب أن لا تتناولي رانيدين إذا كنت حاملاً أو قد تصبحي حاملاً، مالم ينصحك طبيبك أنه من الضروري تناول هذا الدواء.<br />اسألي طبيبك أو الصيدلاني للحصول على المشورة قبل تناول أي دواء، إذا كنت حاملاً.<br />الإرضاع<br />يجب أن لا تتناولي رانيدين إذا كنت مرضعة، مالم ينصحك طبيبك أنه من الضروري تناول هذا الدواء.<br />اسألي طبيبك أو الصيدلاني للحصول على المشورة قبل تناول أي دواء، إذا كنت مرضعة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>دائماً تناول رانيدين بالضبط كما أخبرك طبيبك. يجب أن تسأل طبيبك أو الصيدلاني إذا كنت غير متأكد.<br />تناول هذا الدواء عن طريق الفم □<br />ابتلع كل قرص بأكمله مع كأس من الماء. □<br />الجرعة الاعتيادية للبالغين (بما في ذلك كبار السن) والمراهقين ( ۱۲ سنة فأكثر):<br />إما ۱٥۰ ملغم في الصباح و ۱٥۰ ملغم في المساء، أو ۳۰۰ ملغم عند النوم.<br />ستعتمد الجرعة المحددة لك على الحالة الخاصة بمعدتك، سوف يخبرك طبيبك بالجرعة التي يجب أن تتناولها.<br />الأطفال الذين يزيد وزنهم عن ۳۰ كغم، وتتراوح أعمارهم من ۳ إلى ۱۱ سنة:<br />سيحدد الطبيب الجرعة المناسبة بناءً على وزن طفلك.<br />معالجة قرحة المعدة أو الاثني عشر (الأمعاء الدقيقة): □<br />الجرعة الاعتيادية هي ۲ ملغم لكل كيلوغرام من وزن الجسم، مرتين في اليوم لمدة أربعة أسابيع. ويمكن زيادة هذه الجرعة إلى ٤ ملغم لكل كيلوغرام<br />مرتين في اليوم. تناول كل جرعة على حدا بعد حوالي ۱۲ ساعة. ويمكن زيادة مدة العلاج إلى ۸ أسابيع.<br />علاج حرقة المعدة بسبب كمية الحمض الكثيرة: □<br />الجرعة الاعتيادية هي ۲٫٥ ملغ لكل كيلوغرام من وزن الجسم، مرتين في اليوم لمدة أسبوعين. ويمكن زيادة هذه الجرعة إلى ٥ ملغم لكل كيلوغرام،<br />مرتين في اليوم. تناول كل جرعة على حدا بعد حوالي ۱۲ ساعة.<br />إذا تناولت رانيدين أكثر مما يجب:<br />عادةً لا يسبب رانيدين ضرراً إذا تناولت أكثر من الجرعة المقررة، إلا إذا تناولت أقراص كثيرة في آن واحد. إذا كان هذا ينطبق عليك (أو شخص<br />آخر تناول هذا الدواء)، فإنه يجب عليك الذهاب إلى أقرب مستشفى على الفور. أحضر معك علبة الدواء أو أي أقراص متبقية ليتعرف الطبيب على<br />الدواء الذي قمت بتناوله.<br />إذا نسيت تناول رانيدين:<br />إذا نسيت تناول الجرعة فإنه يجب عليك أن تتناولها بمجرد تذكرها، ما لم يكن موعد الجرعة التالية. لا تضاعف الجرعة لتعويض الجرعة المنسية.<br />إذا توقفت عن تناول رانيدين:<br />سوف تشعر بالتحسن بعد أيام قليلة من تناول الأقراص، لا تتوقف عن تناول الأقراص دون التحدث أولاً إلى طبيبك أو الصيدلاني، وإلا قد يعود الألم<br />والشعور بالانزعاج الذي كنت تعاني منه. اسأل طبيبك أو الصيدلاني، إذا كان لديك أي أسئلة أخرى حول استعمال هذا المستحضر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كغيره من الأدوية، قد يسبب رانيدين آثاراً جانبيةً، بالرغم من أنها لاتحدث للجميع.<br />قد تحدث الآثار الجانبية التالية مع هذا الدواء.<br />توقف عن تناول رانيدين وراجع طبيبك على الفور، إذا لاحظت أياً من هذه الآثار الجانبية الخطيرة التالية، فقد تحتاج إلى معالجة طبية فورية:<br />تفاعلات حساسية، قد تشمل العلامات التالية: □<br />طفح جلدي أو حكة أو شرى □<br />تورم في الوجه أو الشفاه أو اللسان أو أجزاء أخرى من الجسم □<br />ألم في الصدر أو ضيق في التنفس أوالصفير عند التنفس أو صعوبة في التنفس □<br />حمى غير مبررة والشعور بالإغماء، وخصوصاً عند الوقوف. □<br />مشاكل في الكلى، والتي يمكن أن تؤدي إلى آلام الظهر والحمى والألم عند التبول، ودم في البول و تغيرات في فحوصات الدم □<br />ألام حادة في المعدة، وهذا قد يكون علامة على ما يسمى بالتهاب البنكرياس □<br />بطء ضربات القلب أو عدم انتظامها. □<br />استشر طبيبك في الزيارة القادمة إذا لاحظت أياً من الآثار الجانبية التالية:<br />آثار جانبية غير شائعة (التي تؤثر على أقل من شخص في ۱۰۰ شخص):<br />ألم في المعدة □<br />إمساك □ثيان □<br />آثار جانبية نادرة (التي تؤثر على شخص في ۱۰۰۰ شخص):<br />طفح جلدي □<br />آثار جانبية نادرة والتي تظهر في فحوصات الدم:<br />زيادة الكرياتينين في مصل الدم (فحص وظائف الكلى) □<br />تغييرات في وظائف الكبد □<br />استشر طبيبك في أقرب وقت ممكن إذا لاحظت أياً من الآثار الجانبية التالية:<br />آثار جانبية نادرة جداً (التي تؤثر على شخص في ۱۰۰۰۰ شخص):<br />يمكن أن يكون هناك تغييرات في مستوى مواد معينة في الدم. وهذا يمكن أن يؤدي إلى الشعور بالتعب بشكل غيرعادي أو ضيق في التنفس □<br />وتكونأكثر عرضة للكدمات أو الحصول على العدوى<br />الشعور بالاكتئاب، والارتباك، ورؤية أو سماع الأشياء غير المبررة (الهلوسة) □<br />الصداع (شديد في بعض الأحيان) □<br />الشعور بالدوار أو عدم وضوح الرؤية □<br />آلام أو انتفاخ في المفاصل والعضلات وعدم القدرة على التحكم في حركتها □<br />تورم في الأوعية الدموية الصغيرة (المعروف باسم الالتهاب الوعائي)، ويمكن أن يشمل العلامات التالية: طفح جلدي أو تورم المفاصل أو مشاكل □<br />في الكلى<br />تورم في الكبد، وقد يؤدي ذلك إلى: الغثيان أو التقيؤ أو فقدان الشهية أو الشعور بالتوعك بشكل عام و الحكة والحمى واصفرار الجلد والعينين أو □<br />بول داكن اللون<br />توهج وعلامات على الجلد □<br />فقدان الشعر غير المبرر □<br />الإسهال □<br />العجز الجنسي □<br />ألم في الثدي و/ أو تضخم الثدي □<br />إفرازات من الثدي. □<br />يرجى استشارة الطبيب أو الصيدلاني، إذا حدث أياً من هذه الأعراض الجانبية بشدة، أو إذا لاحظت أي آثار جانبية غير المدرجة في هذه</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيداًعن متناول الأطفال. □<br />لا يحفظ بدرجة حرارة أعلى من ۳۰ &deg;م. □<br />لا ينبغي استعمال رانيدين بعد تاريخ انتهاء الصلاحية الموجود على العلبة وعلى شريط الدواء. □<br />لا ينبغي التخلص من الأدوية من خلال مياه الصرف الصحي أو المنزلي. اسأل الصيدلاني عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. سوف<br />تساعد هذه الاجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي رانيتيدين. كل قرص يحتوي على ۱٥۰ ملغم و ۳۰۰ ملغم من رانيتيدين على التوالي، على هيئة رانيتيدين هيدروكلورايد. □<br />المكونات الأخرى هي: هيدروكسي بروبيل سليلوز، سيليكا غروية لامائية، ستيارات المغنيزيوم، بيوتيل هيدروكسي تولوين، ثاني أكسيد التيتانيوم، □<br />ثلاثي الأستين</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            أقراص رانيدين ۱٥۰ و ۳۰۰ ملغم هي أقراص مغلفة بيضاء إلى سكرية اللون، مستديرة، مسطحة، غير منقوشة في كلا الجانبين. □
علب تحتوي على ۲۰ قرص من أقراص رانيدين ۱٥۰ المحفوظة في أشرطة. □
علب تحتوي على ۱۰ قرص من أقراص رانيدين ۳۰۰ المحفوظة في أشرطة. □
ملاحظة: يعتمد حجم العبوة على السوق.
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة الاردنية لانتاج الادوية المساهمة العامة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            كانون الأول ۲۰۱۲
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                RANIDINE 150 mg Film Coated Tablet. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains  Ranitidine as Ranitidine Hydrochloride  150 mg. Inactive Ingredients:

Inactive ingredients(s) and amount (s) per unit dose:
NAMES OF INGREDIENTS	MG/  TABLETS 
Hydroxypropyl Cellulose 	5.40
Butylated Hydroxy Toluene 	1.44
Colloidal Anhydrous Silica 	0.90
Magnesium Stearate 	0.90
Hydroxypropyl Methyl Cellulose Type 2910	11.90
Titanium Dioxide 	4.50
Triacetin	1.50

  
  *For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                RANIDINE 150 Tablet :

White to off-white, circular shallow biconvex film coated plain on both sides.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Adults</strong></p><ul><li>Duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents.</li><li>Prevention of non-steroidal anti-inflammatory drug associated duodenal ulcers.</li><li>Treatment of duodenal ulcers associated with Helicobacter pylori infection.</li><li>Post-operative ulcer.</li><li>Oesophageal reflux disease including long term management of healed oesophagitis.</li><li>Symptomatic relief in gastro-oesophageal reflux disease.</li><li>Zollinger-Ellison Syndrome.</li><li>Chronic episodic dyspepsia, characterised by pain (epigastric or retrosternal) which is related to meals or disturbs sleep but not associated with the above conditions.</li><li>Prophylaxis of gastrointestinal haemorrhage from stress ulceration in seriously ill patients</li><li>Prophylaxis of recurrent haemorrhage with bleeding peptic ulcers.</li><li>Before general anaesthesia in patients at risk of acid aspiration (Mendelson&#39;s syndrome), particularly obstetric patients during labour.</li></ul><p>&nbsp;</p><p><strong>Children (3 to 18 years)</strong></p><ul><li>Short term treatment of peptic ulcer</li><li>Treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Route of administration</strong>: Oral</p><p><strong><u>Adults (including the elderly) / Adolescents (12 years and over)</u></strong></p><p>&nbsp;</p><p>Usual dosage is 150 mg twice daily, taken in the morning and evening.</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Duodenal ulcer, gastric ulcer: </strong></p><p>&nbsp;</p><p>The standard dosage regimen is 150 mg twice daily or 300 mg at night. It is not necessary to time the dose in relation to meals.</p><p>&nbsp;</p><p>In most cases of duodenal ulcer, benign gastric ulcer and post-operative ulcer, healing occurs within 4 weeks. Healing usually occurs after a further 4 weeks of treatment in those not fully healed after the initial course of therapy.</p><p>&nbsp;</p><p><strong>Ulcers following NSAID therapy or associated with continued NSAIDs: </strong></p><p>&nbsp;</p><p>8 weeks treatment may be necessary</p><p>&nbsp;</p><p><strong>Prevention of NSAID associated duodenal ulcers:</strong></p><p><strong>&nbsp;</strong></p><p>150 mg twice daily may be given concomitantly with NSAID therapy.</p><p>&nbsp;</p><p>In duodenal ulcer, 300 mg twice daily for 4 weeks results in healing rates which are higher than those at 4 weeks with ranitidine 150 mg twice daily or 300 mg at night. The increased dose has not been associated with an increased incidence of unwanted effects.</p><p>&nbsp;</p><p><strong>Duodenal ulcers associated with Helicobacter pylori infection: </strong></p><p>&nbsp;</p><p>For duodenal ulcers associated with Helicobacter pylori infection, ranitidine 300 mg at bedtime or 150 mg twice daily may be given with oral amoxicillin 750 mg three times daily and metronidazole 500 mg three times daily for two weeks. Therapy with ranitidine should continue for a further two weeks. This dose regimen significantly reduces the frequency of duodenal ulcer recurrence.</p><p>&nbsp;</p><p>Maintenance treatment at a reduced dosage of 150 mg at bedtime is recommended for patients who have responded to short term therapy, particularly those with a history of recurrent ulcer.</p><p>&nbsp;</p><p><strong>Gastro-oesophageal reflux disease: </strong></p><p><strong>&nbsp;</strong></p><p>Symptom relief in gastro-oesophageal reflux disease. In patients with gastro-oesophageal reflux disease, a dose regimen of 150 mg twice daily for 2 weeks is recommended and this can be repeated in patients in whom the initial symptomatic response is inadequate</p><p><strong>&nbsp;</strong></p><p><strong>Oesophageal reflux disease: </strong></p><p>&nbsp;</p><p>In the management of oesophageal reflux disease, the recommended course of treatment is either 150 mg twice daily or 300 mg at bedtime for up to 8 weeks or 12 weeks if necessary.</p><p>In patients with moderate to severe oesophagitis, the dosage of ranitidine may be increased to 150 mg 4 times daily for up to 12 weeks. The increased dose has not been associated with an increased incidence of unwanted effects.</p><p><strong>Healed oesophagitis: </strong></p><p>&nbsp;</p><p>For long term treatment, recommended adult dose is 150 mg twice daily. Long term treatment is not indicated in management of patients with unhealed oesophagitis with or without Barrett&#39;s epithelium.</p><p><strong>&nbsp;</strong></p><p><strong>Zollinger-Ellison syndrome: </strong></p><p>&nbsp;</p><p>The starting dose for Zollinger-Ellison syndrome is 150 mg three times daily, and this may be increased as necessary. Doses up to 6 grams per day have been well tolerated.</p><p>&nbsp;</p><p><strong>Chronic episodic dyspepsia: </strong></p><p>&nbsp;</p><p>The standard dosage regimen for patients with chronic episodic dyspepsia is &nbsp;150 mg twice daily for up to 6 weeks. Anyone not responding or relapsing shortly afterwards should be investigated.</p><p>&nbsp;</p><p><strong>Prophylaxis of haemorrhage from stress ulceration in seriously ill patients or prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration: </strong></p><p>&nbsp;</p><p>150 mg twice daily may be substituted for the injection once oral feeding commences.</p><p>&nbsp;</p><p><strong>Prophylaxis of acid aspiration (Mendelson&#39;s) syndrome: </strong></p><p><strong>&nbsp;</strong></p><p>150 mg oral dose can be given 2 hours before anaesthesia, and preferably also&nbsp;&nbsp; 150 mg the previous evening. Alternatively, the injection is also available. In obstetric patients in labour 150 mg every 6 hours, but if general anaesthesia is required it is recommended that a non-particulate antacid (e.g. sodium citrate) be given in addition. The usual precautions to avoid acid aspiration should also be taken.</p><p>&nbsp;</p><p><strong><u>Children from 3 to 11 years and over 30 kg of weight </u></strong></p><p>&nbsp;</p><p>&sect;&nbsp; Treatment of stomach or duodenal (small intestine) ulcers:</p><p>The usual dose is 2 mg for each kg of body weight, twice a day for four weeks. This dose may be increased to 4mg for each kg, twice a day. Take each dose about 12 hours apart. The duration of treatment may be increased to 8 weeks.</p><p>&nbsp;</p><p>&sect;&nbsp; Treatment of heartburn due to too much acid:</p><p>The usual dose is 2.5 mg for each kg of body weight, twice a day for two weeks. This dose may be increased to 5 mg for each kg, twice a day. Take each dose about<br />12 hours apart.</p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>Patients over 50 years of age </u></strong></p><p><strong><u>&nbsp;</u></strong></p><p>See Section 5.2 Pharmacokinetic Properties (Special Patient Populations, Patients over 50 years of age)</p><p>&nbsp;</p><p><strong><u>Peptic Ulcer Acute Treatment</u></strong></p><p>&nbsp;</p><p>The recommended oral dose for the treatment of peptic ulcer in children is 4 mg/kg/day to 8 mg/kg/day administered as two divided doses to a maximum of 300 mg ranitidine per day for a duration of 4 weeks. For those patients with complete healing, another 4 weeks of therapy is indicated, as healing usually occurs after eight weeks of treatment.</p><p>&nbsp;</p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>Gastro-Oesophageal Reflux</u></strong></p><p><strong><u>&nbsp;</u></strong></p><p>The recommended oral dose for the treatment of gastro-oesophageal reflux in children is 5 mg/kg/day to 10 mg/kg/day administered as two divided doses to a maximum of 600 mg (the maximum dose is likely to apply to heavier children or adolescents with severe symptoms).</p><p>Safety and efficacy in new-born patients has not been established.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong><u>Renal Impairment:</u></strong></p><p>&nbsp;</p><p>Accumulation of ranitidine with resulting elevated plasma concentrations will occur in patients with renal impairment (creatinine clearance less than 50 ml/min).</p><p>Accordingly, it is recommended that the daily dose of ranitidine in such patients should be 150 mg at night for 4-8 weeks. The same dose should be used for maintenance treatment, if necessary. If an ulcer has not healed after treatment, 150 mg twice daily dosage should be instituted followed, if need be, by maintenance treatment of 150 mg at night.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ranitidine is contra-indicated in patients known to have hypersensitivity to any component of the preparation
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The possibility of malignancy should be excluded before commencement of therapy in patients with gastric ulcer (and if indications include dyspepsia, patients of middle age and over with new or recently changed dyspeptic symptoms) as treatment with ranitidine may mask symptoms of gastric carcinoma.</p><p>&nbsp;</p><p><strong>Renal Disease: </strong></p><p><strong>&nbsp;</strong></p><p>Ranitidine is excreted via the kidney and so plasma levels of the drug are increased in patients with renal impairment. The dosage should be adjusted as detailed in section 4.2 in Renal Impairment.</p><p>Regular supervision of patients who are taking non-steroidal anti-inflammatory drugs concomitantly with ranitidine is recommended, especially in the elderly and in those with a history of peptic ulcer.</p><p>Rare clinical reports suggest that ranitidine may precipitate acute porphyric attacks. Ranitidine should therefore be avoided in patients with a history of acute porphyria.</p><p><strong>&nbsp;</strong></p><p><strong>Use in elderly patients:</strong></p><p><strong>&nbsp;</strong></p><p>In patients such as the elderly, persons with chronic lung disease, diabetes or the immunocompromised, there may be an increased risk of developing community acquired pneumonia. A large epidemiological study showed an increased risk of developing community acquired pneumonia in current users of ranitidine alone versus those who had stopped treatment, with an observed adjusted relative risk increase of 1.82 (95% CI 1.26-2.64). Postmarketing data indicate reversible mental confusion, depression, and hallucinations have been reported most frequently in severely ill and elderly patients (see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ranitidine has the potential to affect the absorption, metabolism or renal excretion of other drugs. The altered pharmacokinetics may necessitate dosage adjustment of the affected drug or discontinuation of treatment</p><p>&nbsp;</p><p>Interactions occur by several mechanisms including:</p><p>&nbsp;</p><p>1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inhibition of cytochrome P450-linked mixed function oxygenase system:</p><p>2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p><p>Ranitidine at usual therapeutic doses does not potentiate the actions of drugs which are inactivated by this enzyme system such as diazepam, lidocaine, phenytoin, propanolol and theophylline.</p><p>There have been reports of altered prothrombin time with coumarin anticoagulants (e.g. warfarin). Due to the narrow therapeutic index, close monitoring of increased or decreased prothrombin time is recommended during concurrent treatment with ranitidine.</p><p>&nbsp;</p><p>&nbsp;</p><p>3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Competition for renal tubular secretion:</p><p>&nbsp;</p><p>Since ranitidine is partially eliminated by the cationic system, it may affect the clearance of other drugs eliminated by this route. High doses of ranitidine (e.g. such as those used in the treatment of Zollinger-Ellison syndrome) may reduce the excretion of procainamide and N-acetylprocainamide resulting in increased plasma level of these drugs.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Alteration of gastric pH:</p><p>&nbsp;</p><p>The bioavailability of certain drugs may be affected. This can result in either an increase in absorption (e.g. triazolam, midazolam, glipizide) or a decrease in absorption (e.g. ketoconazole, atazanavir, delaviridine, gefitnib).</p><p>&nbsp;</p><p>There is no evidence of an interaction between ranitidine and -amoxicillin or metronidazole</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ranitidine crosses the placenta but therapeutic doses administered to obstetric patients in labour or undergoing caesarean section have been without any adverse effect on labour, delivery or subsequent neonatal progress. It is excreted in human breast milk.</p><p>Like other drugs it should only be used during pregnancy and nursing if considered essential.</p><p>There are no data on the effects of ranitidine on human fertility. There were no effects on male and female fertility in animal studies</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following convention has been utilised for the classification of undesirable effects: very common (&ge;1/10), common (&ge;1/100, &lt;1/10), uncommon (&ge;1/1000, &le;1/100), rare (&ge;1/10,000, &le;1/1000), very rare (&le;1/10,000).Adverse event frequencies have been estimated from spontaneous reports from post-marketing data.</p><p><strong>Blood &amp; Lymphatic System Disorders</strong></p><p>Very Rare:</p><p>Blood count changes (leucopenia, thrombocytopenia). These are usually reversible. Agranulocytosis or pancytopenia, sometimes with marrow hypoplasia or marrow aplasia.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Immune System Disorders</strong></p><p>Rare:</p><p>Hypersensitivity reactions (urticaria, angioneurotic oedema, fever, bronchospasm, hypotension and chest pain).</p><p>Very Rare:</p><p>Anaphylactic shock.</p><p>These events have been reported after a single dose.</p><p><strong>Psychiatric Disorders</strong></p><p>Very Rare:</p><p>Reversible mental confusion, depression and hallucinations.</p><p>These have been reported predominantly in severely ill and elderly patients.</p><p><strong>Nervous System Disorders</strong></p><p>Very Rare:</p><p>Headache (sometimes severe), dizziness.and reversible involuntary movement disorders.</p><p><strong>Eye Disorders</strong></p><p>Very Rare:</p><p>Reversible blurred vision.</p><p>There have been reports of blurred vision, which is suggestive of a change in accommodation.</p><p><strong>Cardiac Disorders</strong></p><p>Very Rare:</p><p>As with other H<sub>2</sub> receptor antagonists bradycardia and A-V Block.</p><p><strong>Vascular Disorders</strong></p><p>Very Rare:</p><p>Vasculitis.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Gastrointestinal Disorders</strong></p><p>Uncommon:</p><p>Abdominal pain, constipation, nausea (these symptoms mostly improved during continued treatment).</p><p>Very Rare:</p><p>Acute pancreatitis, diarrhoea</p><p><strong>Hepatobiliary Disorders</strong></p><p>Rare:</p><p>Transient and reversible changes in liver function tests.</p><p>Very Rare:</p><p>Hepatitis (hepatocellular, hepatocanalicular or mixed) with or without jaundice, these were usually reversible.</p><p><strong>Skin and Subcutaneous Tissue Disorders</strong></p><p>Rare:</p><p>Skin Rash.</p><p>Very Rare:</p><p>Erythema multiforme, alopecia.</p><p><strong>Musculoskeletal and Connective Tissue Disorders</strong></p><p>Very Rare:</p><p>Musculoskeletal symptoms such as arthralgia and myalgia.</p><p><strong>Renal and Urinary Disorders</strong></p><p>Rare:</p><p>Elevation of plasma creatinine (usually slight; normalised during continued treatment)</p><p>Very Rare:</p><p>Acute interstitial nephritis.</p><p><strong>Reproductive System and Breast Disorders</strong></p><p>Very Rare:</p><p>Reversible impotence, breast symptoms and breast conditions (such as gynaecomastia and galactorrhoea).</p><p>The safety of ranitidine has been assessed in children aged 0 to 16 years with acid-related disease and was generally well tolerated with an adverse event profile resembling that in adults. There are limited long term safety data available, in particular regarding growth and development.</p><p>&nbsp;</p><p>To report any side effect (s):</p><p>&nbsp;Saudi Arabia: National Pharmacovigilance &amp; Drug Safety Centre (NPC)</p><p>&nbsp;</p><ul><li>Fax: +966-11-205-7662</li><li>Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</li><li>Toll free phone: 8002490000</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: www.sfda.gov.sa/npc</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ranitidine is very specific in action and accordingly no particular problems are expected following overdosage. Symptomatic and supportive therapy should be given as appropriate</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong></p><p>Pharmacotherapeutic group: H2-receptor antagonists</p><p>ATC code: A02BA02</p><p>&nbsp;</p><p>Ranitidine is a specific rapidly acting histamine H2-antagonist. It inhibits basal and stimulated secretion of gastric acid, reducing both the volume and the acid and pepsin content of the secretion. Ranitidine has a relatively long duration of action and so a single 150 mg dose effectively suppresses gastric acid secretion for twelve hours.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>Following oral administration of 150 mg ranitidine, maximum plasma concentrations (300 to 550 ng/mL) occurred after 1&mdash;3 hours. Two distinct peaks or plateau in the absorption phase result from reabsorption of drug excreted into the intestine. The absolute bioavailability of ranitidine is 50-60% and plasma concentrations increase proportionally with increasing dose up to 300 mg.</p><p><strong>Distribution</strong></p><p>Ranitidine is not extensively bound to plasma proteins (15%), but exhibits a large volume of distribution ranging from 96 to 142 L.</p><p><strong>Metabolism</strong></p><p>Ranitidine is not extensively metabolised. The fraction of the dose recovered as metabolites is similar after both oral and i.v. dosing; and includes 6% of the dose in urine as the N-oxide, 2% as the S-oxide, 2% as desmethylranitidine and 1 to 2% as the furoic acid analogue.</p><p>&nbsp;</p><p><strong>Elimination </strong></p><p>Plasma concentrations decline bi-exponentially, with a terminal half-life of 2-3 hours. The major route of elimination is renal. After IV administration of 150 mg 3H-ranitidine, 98% of the dose was recovered, including 5% in faeces and 93% in urine, of which 70% was unchanged parent drug. After oral administration of 150 mg 3H-ranitidine, 96% of the dose was recovered, 26% in faeces and 70% in urine of which 35% was unchanged parent drug. Less than 3% of the dose is excreted in bile. Renal clearance is approximately 500 mL/min, which exceeds glomerular filtration indicating net renal tubular secretion.</p><p><u>Special Patient Populations</u></p><p><u>Children (3 years and above)</u></p><p>Limited pharmacokinetic data show that there are no significant differences in half-life (range for children 3 years and above: 1.7 - 2.2 h) and plasma clearance (range for children 3 years and above: 9 - 22 ml/min/kg) between children and healthy adults receiving oral ranitidine when correction is made for body weight.</p><p><u>Patients over 50 years of age</u></p><p>In patients over 50 years of age, half-life is prolonged (3-4 h) and clearance is reduced, consistent with the age-related decline of renal function. However, systemic exposure and accumulation are 50% higher. This difference exceeds the effect of declining renal function, and indicates increased bioavailability in older patients</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>Following oral administration of 150 mg ranitidine, maximum plasma concentrations (300 to 550 ng/mL) occurred after 1&mdash;3 hours. Two distinct peaks or plateau in the absorption phase result from reabsorption of drug excreted into the intestine. The absolute bioavailability of ranitidine is 50-60% and plasma concentrations increase proportionally with increasing dose up to 300 mg.</p><p><strong>Distribution</strong></p><p>Ranitidine is not extensively bound to plasma proteins (15%), but exhibits a large volume of distribution ranging from 96 to 142 L.</p><p><strong>Metabolism</strong></p><p>Ranitidine is not extensively metabolised. The fraction of the dose recovered as metabolites is similar after both oral and i.v. dosing; and includes 6% of the dose in urine as the N-oxide, 2% as the S-oxide, 2% as desmethylranitidine and 1 to 2% as the furoic acid analogue.</p><p>&nbsp;</p><p><strong>Elimination </strong></p><p>Plasma concentrations decline bi-exponentially, with a terminal half-life of 2-3 hours. The major route of elimination is renal. After IV administration of 150 mg 3H-ranitidine, 98% of the dose was recovered, including 5% in faeces and 93% in urine, of which 70% was unchanged parent drug. After oral administration of 150 mg 3H-ranitidine, 96% of the dose was recovered, 26% in faeces and 70% in urine of which 35% was unchanged parent drug. Less than 3% of the dose is excreted in bile. Renal clearance is approximately 500 mL/min, which exceeds glomerular filtration indicating net renal tubular secretion.</p><p><u>Special Patient Populations</u></p><p><u>Children (3 years and above)</u></p><p>Limited pharmacokinetic data show that there are no significant differences in half-life (range for children 3 years and above: 1.7 - 2.2 h) and plasma clearance (range for children 3 years and above: 9 - 22 ml/min/kg) between children and healthy adults receiving oral ranitidine when correction is made for body weight.</p><p><u>Patients over 50 years of age</u></p><p>In patients over 50 years of age, half-life is prolonged (3-4 h) and clearance is reduced, consistent with the age-related decline of renal function. However, systemic exposure and accumulation are 50% higher. This difference exceeds the effect of declining renal function, and indicates increased bioavailability in older patients</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hydroxypropyl Cellulose (Klucel EF)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Butylated Hydroxy Toluene</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Colloidal Anhydrous Silica</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Magnesium Stearate</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hydroxypropyl Methyl Cellulose Type 2910</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Titanium Dioxide</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Triacetin</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Three  years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 30&ordm;C, protected from humidity.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>RANIDINE 150 mg Tablets are packed in boxes of 20 Tablets blistered in &nbsp;</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PVC/PVDC /Aluminium Foil Blisters</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of accordance with local requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Jordanian Pharmaceutical Manufacturing Co. Ltd.
PO Box 151
Um Al-Amad 16197
Jordan

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                April 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>